MS Speaks
Multiple Sclerosis => TREATMENTS => KESIMPTA (ofatumumab) => Topic started by: agate on March 07, 2025, 07:00:57 am
-
From PubMed (March 7, 2025)--"Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis":
https://pubmed.ncbi.nlm.nih.gov/40050009/